CircuLite®, Inc. Company Profile
CircuLite is developing disruptive solutions to improve the treatment of chronic heart failure. The Company’s minimally invasive circulatory support systems are intended to work in conjunction with the heart to enhance clinical outcomes and improve quality of life for patients and their families. Synergy®, currently in a CE Mark clinical trial, features the world’s smallest surgically implanted blood pump for long-term use in patients diagnosed with heart failure. Next-generation circulatory support systems in development that incorporate CircuLite's micro-pump technology include an endovascular system, a right-heart system, a pediatric system, and an all-support system. For more information, visit our website at www.circulite.net.
News Articles
CircuLite gains FDA approval for blood pump study
The FDA has granted CircuLite investigational device exemption approval to launch a clinical study of its SYNERGY Circulatory -More-
CircuLite: Treating Heart Failure’s Lost Patients
Even with all of the advances and options in heart failure therapy, there remain no real options for a large number of patients who are seriously ill but not yet at the end-stage of the disease. Circu...
CircuLite to begin CE Mark trial of Synergy IC Circulatory Support System
CircuLite has received an approval from the Federal Agency for Medicines and Health Products to begin the CE Mark trial of the Synergy IC Circulatory Support System (SICSS), which is designed for inte...
CircuLite®, Inc. today announced the SYNERGY® Circulatory Support System will be included in two presentations at the 26th Annual Meeting of the European Association for...
CircuLite® Announces Four Presentations at Transcatheter Cardiovascular Therapeutics Conference
CircuLite®, Inc. today announced its SYNERGY® Circulatory Support System will be included in four presentations at the 24th Annual Transcatheter Cardiovascular Therapeuti...
Eric Rose, M.D., Named Chairman of the CircuLite® Board of Directors
CircuLite®, Inc. today announced the appointment of Eric Rose, M.D., as Chairman of its Board of Directors. Dr. Rose is a recognized leader in academic medicine and surg...
CircuLite® Receives CE Marking Approval for SYNERGY® Circulatory Support System
CircuLite®, Inc. today announced that it has received CE Marking approval for the SYNERGY® Circulatory Support System, a micro-pump designed to halt the progressio...
CircuLite obtains EU approval for mini heart pump
CircuLite has received CE mark approval in Europe to market its SYNERGY mini blood pump system, which can pump 4.25 liters of -More-
Drugs and Medications
None
PubMed Articles
None
Clinical Trials
Safety and Performance Evaluation of CircuLite Synergy
The purpose of the study is to demonstrate the safety and functionality of the CircuLite Synergy Pocket Circulatory Assist Device.
Companies
CircuLite® is transforming heart failure treatment with the development of minimally invasive devices for long-term partial circulatory support (PCS). By enabling a proactive a...
CircuLite is developing disruptive solutions to improve the treatment of chronic heart failure. The Company’s minimally invasive circulatory support systems are intended to w...
CircuLite is developing disruptive solutions to improve the treatment of advanced heart failure. The Company’s minimally invasive circulatory support systems are intended to...
More Information about "CircuLite®, Inc." on BioPortfolio
We have published hundreds of CircuLite®, Inc. news stories on BioPortfolio along with dozens of CircuLite®, Inc. Clinical Trials and PubMed Articles about CircuLite®, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of CircuLite®, Inc. Companies in our database. You can also find out about relevant CircuLite®, Inc. Drugs and Medications on this site too.
